The effects of clonazepam and vigabatrin in hyperekplexia

Journal of the Neurological Sciences

Volumn 149, Issue 1, 1997, Pages 63-67

  Tijssen, M A J ^a   Schoemaker, H C ^a   Edelbroek, P J ^b   Roos, R A C ^a   Cohen, A F ^a   Van Dijk, J G ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Instituut voor Epilepsiebestrijding   (Netherlands)

Author keywords

clonazepam; hyperekplexia; startle; vigabatrin

Indexed keywords

CLONAZEPAM; VIGABATRIN;

ADULT; ARTICLE; AUDITORY STIMULATION; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ELECTROMYOGRAM; GABAERGIC SYSTEM; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STARTLE EPILEPSY; STARTLE REFLEX;

ACOUSTIC STIMULATION; ADULT; ANTICONVULSANTS; CLONAZEPAM; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTROMYOGRAPHY; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; MUSCLE RIGIDITY; PLACEBOS; POINT MUTATION; RECEPTORS, GLYCINE; SLEEP STAGES; STARTLE REACTION; VIGABATRIN;

EID: 0030987119     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)05378-1     Document Type: Article

References (33)

1. Andermann, F., Keene, D.L., Andermann, E. and Quesney, L.F. (1980) Startle disease or hyperekplexia: further delineation of the syndrome. Brain, 103: 985-997.
2. Berthier, M., Bonneau, D., Desbordes, J.M., et al. (1994) Possible involvement of a gamma-hydroxybutyric acid receptor in startle disease. Acta Paediatr., 83: 678-680.
3. Brown, P., Rothwell, J.C., Thompson, P.D., et al. (1991) The hyperekplexias and their relationship to the normal startle reflex. Brain, 114: 1903-1928.
4. Brown, R.T. (1976) Clonazepam: a review of a new anticonvulsant drug. Arch. Neurol., 33; 326-332.
5. Bond, A. and Lader, M. (1974) The use of analogue scales in rating subjective feelings. Br. J. Med. Psychol., 47: 211-218.
6. Dooley, J.M. and Andermann, F. (1989) Startle disease or hyperekplexia: adolescent onset and response to valproate. Pediatr. Neurol., 5: 126-127.
7. Dreifuss, F.E. and Sato, S. (1982) Benzodiazepines, Clonazepam. In: Woodbury D.M. et al. Antiepileptic Drugs, 2nd ed. Raven press, New York, NY, pp. 737-752.
8. Dubowitz, L.M.S., Bouza, H., Hird, M.F. and Jaeken, J. (1992) Low cerebrospinal fluid concentration of free gamma-aminobutyric acid in startle disease. Lancet, 340; 80-81.
9. Gastaut, H. and Villeneuve, A. (1967) The startle disease or hyperekplexia, pathological surprise reaction. J. Neurol. Sci., 5: 523-542.
10. Hayashi, T., Tachibana, H. and Kajii, T. (1991) Hyperekplexia: pedigree studies in two families. Am. J. Med. Genet., 40: 138-143.
11. Kelts, K.A. and Harrison, J. (1988) Hyperekplexia: Effective treatment with clonazepam. Ann. Neurol., 24: 309.
12. Klein, R., Haddow, J.E. and DeLuca, C. (1972) Familial congenital disorder resembling stiff-man syndrome. Am. J. Dis. Child., 124: 730-732.
13. Langosch, D., Laube, B., Rundström, N., et al. (1994) Decreased agonist affinity and chloride conductance of mutant glycine receptors associated with human hereditary hyperekplexia. EMBO J., 18: 4223-4228.
14. Markand et al. (1984) Familial startle disease (Hyperekplexia). Arch. Neurol., 41: 71-74.
15. McAbee, G.N., Kadakia, S.K., Sisley, K.C., et al. (1995) Complete heart block in nonfamilial hyperekplexia. Pediatr. Neurol., 12: 149-151.
16. Melki, I., Rizkallah, E. and Akatcherian, C. (1988) L'hyperexplexia: la maladie du sursaut. Pédiatrie, 43: 35-37.
17. Meyer, J.W.A. (1991) Knowledge, attitude and practice in antiepileptic drug monitoring. Acta Neurol. Scand., suppl., 83: 1-28.
18. Morley, D.J., Weaver, D.D., Garg, B.P. and Markand, O. (1982) Hyperekplexia: an inherited disorder of startle response. Clin. Genet., 21: 388-396.
19. Mumford, J.P. and Lewis, P.J. (1991) Vigabatrin. In: New antiepileptic drugs. Elsevier, Amsterdam.
20. Pascotto, A. and Coppola, G. (1992) Neonatal hyperekplexia: A case report. Epilepsia, 33: 817-820.
21. Rajendra, S., Lynch, J.W., Pierce, K.D., et al. (1995) Mutation of an arginine residue in the human glycine receptor transforms β-alanine and taurine from agonists into competitive antagonists. Neuron, 14: 169-175.
22. Ryan, S.G., Dixon, M.J., Nigro, M.A., et al. (1992) Genetic and radiation hybrid mapping of the Hyperekplexia region on chromosome 5q. Am. J. Hum. Genet, 51: 1334-1343.
23. Saenz-Lope, E., Herranz-Tanarro, F.J., Masdeu, J.C., Chacon and Pena, R. (1984) Hyperekplexia: A syndrome of pathological startle responses. Ann. Neurol., 15: 36-41.
24. Sato, S. (1989) Benzodiazepines, clonazepam. In: R.H. Levy et al. (Eds.), Antiepileptic Drugs, 3rd ed. Raven Press, New York, NY, pp. 765-784.
25. Schmieden, V., Kuhse, J. and Betz, H. (1993) Mutation of glycine receptor subunit creates β-alanine receptor responsive to GABA. Science, 262: 256-258.
26. Shahar, E., Brand, N., Uziel, Y. and Barak, Y. (1991) Nose tapping test inducing a generalized flexor spasm: a hallmark of Hyperekplexia. Acta, Paediatr. Scand., 80: 1073-1077.
27. Shiang, R., Ryan, S.G., Zhu, Y., et al. (1993) Mutations in the cd subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nat. Genet., 5: 351-357.
28. Shiang, R., Ryan, S.G., Zhen, Z.R., et al. (1995) Mutational analysis of familial and sporadic hyperekplexia. Ann. Neurol., 38: 85-91.
29. Simon, E.S. (1995) Involvement of glycine and GABAA receptors in the pathogenesis of spinal myoclonus: In vitro studies in the isolated neonatal rodent spinal cord. Neurology, 45: 1883-1892.
30. Stephenson, J.B.P. (1992) Vigabatrin for startle disease with altered cerebrospinal-fluid free gamma-aminoabutyric acid. Lancet, 340: 430-431.
31. Suhren, O., Bruyn, G.W. and Tuynman, A. (1966) Hyperekplexia, a hereditary startle syndrome. J. Neurol. Sci., 3: 577-605.
32. Tijssen, M.A.J., Shiang, R., Deutekom, J. van, et al. (1995) Molecular genetic reevaluation of the Dutch hyperekplexia family. Arch. Neurol., 52: 578-582.
33. Tijssen, M.A.J., Padberg, G.W., van Dijk, J.G. (1996) The startle pattern in the minor form of hyperekplexia. Arch. Neurol., 53: 608-613.